Edition:
United States

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

1.45USD
19 May 2017
Change (% chg)

-- (--)
Prev Close
$1.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
153,628
52-wk High
$6.22
52-wk Low
$0.95

RGLS.OQ

Chart for RGLS.OQ

About

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a range of diseases. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs to modulate microRNAs and return... (more)

Overall

Beta: 1.57
Market Cap(Mil.): $77.11
Shares Outstanding(Mil.): 53.18
Dividend: --
Yield (%): --

Financials

  RGLS.OQ Industry Sector
P/E (TTM): -- 142.93 17.37
EPS (TTM): -1.53 -- --
ROI: -86.38 2.34 -5.89
ROE: -110.51 0.22 -5.30

BRIEF-Regulus reports Q4 loss per share $0.38

* Regulus reports fourth quarter 2016 financial results and pipeline update

Mar 02 2017

BRIEF-Regulus Therapeutics announces continuation of RG-101 clinical hold

* Received written communication from FDA that clinical development program for RG-101 remains on clinical hold

Jan 27 2017

More From Around the Web

Competitors

Earnings vs. Estimates